Demo supplier transparency profile

Nova Synthesis Registry

listed

Demo listed supplier with structured CoA uploads, identity confirmation records, and review-ready documentation trail. Has active dispute on one batch currently under review.

Germany
Country
78%
Completeness
4
Batches
2
Lab-auth
1
Disputes

Documentation standards

  • Batch number and certificate ID must reconcile.
  • Test method, date, lab and document fingerprint are displayed.
  • Statuses are conservative and do not imply safety, legality, or product endorsement.
  • Supplier contact is restricted to documentation/business enquiries only.
Optional contact workflow: Request supporting documentation from PurityLedger. No purchase, order, dosing, protocol, or human-use enquiries.

Batch history

PL-NV-260511-HPLC04Disputed

Tirzepatide (Research Reference) · HPLC

PL-NV-260501-LCMS05Expired

Ipamorelin (Research Reference) · HPLC / LC-MS

PL-NV-260508-ENDO18Retested

BPC-157 (Research Reference) · HPLC / LC-MS / endotoxin

PL-NV-260514-LCMS19Lab-authenticated

AOD-9604 (Research Reference) · HPLC / LC-MS

PL-NV-260511-HPLC04

Tirzepatide (Research Reference)

Batch NV-TIR-0526 · HPLC

Disputed

Batch-to-certificate mismatch flagged; document consistency review in progress at Rhein MassSpec

Open verification record →

PL-NV-260501-LCMS05

Ipamorelin (Research Reference)

Batch NV-IPA-0426 · HPLC / LC-MS

Expired

Record review window expired; updated documentation requested from Nova Synthesis Registry

Open verification record →

PL-NV-260508-ENDO18

BPC-157 (Research Reference)

Batch NV-BPC157-0526 · HPLC / LC-MS / endotoxin

Retested

Retest packet reconciled with original batch record at Rhein MassSpec; endotoxin panel included in retest

Open verification record →

PL-NV-260514-LCMS19

AOD-9604 (Research Reference)

Batch NV-AOD9604-0526 · HPLC / LC-MS

Lab-authenticated

Rhein MassSpec lab-authenticated workflow complete; HPLC and LC-MS documentation confirmed

Open verification record →

Record history

2026-04-26 · Batch record created

sha256:2f745ba4cdafdc964d827929984845ac823a4d219884aa7906436131db2e6380

2026-04-28 · Documents received and fingerprinted

sha256:2f745ba4cdafdc964d827929984845ac823a4d219884aa7906436131db2e6380

2026-04-28 · Mismatch flagged — review initiated

sha256:2f745ba4cdafdc964d827929984845ac823a4d219884aa7906436131db2e6380

2026-05-22 · Final documentation status recorded

sha256:2f745ba4cdafdc964d827929984845ac823a4d219884aa7906436131db2e6380

2026-04-12 · Batch record created

sha256:7ef0b02a458cf04db9b71f74338ad9ef326261ea502594e39171c5a1c279a6af

2026-04-16 · Documents received and fingerprinted

sha256:7ef0b02a458cf04db9b71f74338ad9ef326261ea502594e39171c5a1c279a6af

2026-04-21 · Review status updated

sha256:7ef0b02a458cf04db9b71f74338ad9ef326261ea502594e39171c5a1c279a6af

2026-05-30 · Final documentation status recorded

sha256:7ef0b02a458cf04db9b71f74338ad9ef326261ea502594e39171c5a1c279a6af

Dispute / retest history

2026-05-22: Certificate ID did not match supplier-uploaded batch number in original Tirzepatide documentation packet.Disputed

Important limitation: This record does not certify safety, legality, efficacy, approval, or suitability for human/veterinary use.

PurityLedger provides documentation review, batch record hosting, CoA verification tools and analytical testing coordination only. PurityLedger does not certify any product as safe, effective, legal, approved, or suitable for human or veterinary use. Testing records are batch-specific and do not constitute medical advice, regulatory approval, or endorsement of any supplier or product. Clients and users are responsible for compliance with applicable laws in their jurisdiction.